The way I see it. is that the embedded system is months or even a year away from an actual order and don't expect any price impact from this earlier announcement.

And additional lawsuits may have a transitory effect but any sustained price increase will only result from actual recurrent settlements.

It's difficult to explain the downward trend over the recent quarters, except that the groups that supply edig with cash infusions seem to control the price each when operating funds are needed to generate maximum amounts of shares in exchange.